Clinical Trials Browser

Phase 3 × Lung Diseases × Erlotinib Hydrochloride × Clear all

NCT02134015 2018-01-23

HER3-Lung

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms